コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sing the T cell antigen receptor beta-chain (TCRbeta).
2 nd mRNA sequencing of their TCR beta-chains (TCRbeta).
3 splacing cholesterol, which is known to bind TCRbeta.
4 the Vbeta1412-RS with the 3'Dbeta112-RS on a TCRbeta allele lacking Dbeta segments (the Jbeta1(M6) al
5 x on the Jbeta1(omega) allele, an endogenous TCRbeta allele that lacks the Dbeta2-Jbeta2 cluster, cre
7 ey might be regulated, we analyzed mice with TCRbeta alleles containing preassembled functional Vbeta
8 y, Vbeta14(Rep) recombination also occurs on TCRbeta alleles lacking endogenous Vbeta to DJbeta rearr
9 earrangements occur on only 5% of endogenous TCRbeta alleles, the Vbeta14(Rep) cassette underwent rea
10 machinery cooperate to help enforce IgH and TCRbeta allelic exclusion and indicate that control of V
11 ndogenous VbetaDJbetaCbeta genes can enforce TCRbeta allelic exclusion and reveal another mechanism t
15 /lipid complex and high prevalence of Vbeta7 TCRbeta among the CD8(+) iNKT cells strongly point to a
17 In these individuals, T cell receptor beta (TCRbeta) analysis revealed that class II-restricted CD8(
23 tween alleles is more strictly regulated for TCRbeta and IgH loci, we evaluated the ability of ATM to
24 reduced D-to-J and V-to-DJ rearrangements of TCRbeta and IgH loci, whereas Rag2(C/C) mice show decrea
25 have been reported to increase the level of TCRbeta and Igmicro pre-mRNA, suggesting the hypothesis
29 of inter-chromosomal translocations between TCRbeta and TCRdelta D gene segments are also increased
30 stage following successful rearrangement of Tcrbeta, and is triggered by and dependent on concurrent
34 f gammadelta T cells and CD3(+)CD4(+)CD44(hi)TCRbeta(+)CCR6(+) natural Th17 (nTh17) cells, but not by
36 a population, BATF-expressing NKT cells are TCRbeta/CD3epsilon(low), but express normal levels of CD
38 s transient self-renewal (beta-selection) of TCRbeta(+) CD4(-)CD8(-) double-negative stage 3 (DN3) an
39 of the IEL subpopulations TCRgammadelta(+), TCRbeta(+)CD4(+), TCRbeta(+)CD4(+)CD8alpha(+), and TCRbe
40 ulations TCRgammadelta(+), TCRbeta(+)CD4(+), TCRbeta(+)CD4(+)CD8alpha(+), and TCRbeta(+)CD8alphaalpha
41 mice have greater numbers of IL-17-producing TCRbeta(+)CD4(+)cells in lymphoid organs and in the inte
42 We defined two precursor populations among TCRbeta(+)CD4(-)CD8(-) thymocytes by dependence on the k
43 metry subsequently confirmed the presence of TCRbeta(+) CD8(+) IL-17(+) T cells among tumor-infiltrat
44 a(+)CD4(+), TCRbeta(+)CD4(+)CD8alpha(+), and TCRbeta(+)CD8alphaalpha(+) cells in comparison with wild
45 h classifier, we extracted 4-mers from every TCRbeta CDR3 and represented each 4-mer using biophysico
46 ore, we observed that T cells with identical TCRbeta CDR3 nucleotide sequences were capable of recogn
47 l repertoire formation using high throughput TCRbeta CDR3 sequencing in immunodeficient mice receivin
50 ed expansion and enrichment of intracellular TCRbeta(+) cells within the DN population and increased
54 performed high-throughput sequencing of the TCRbeta chain complementarity-determining region 3 of li
55 we induced a CRISPR/Cas9-mediated KO of the TCRbeta chain in combination with a second-generation re
57 lecular level, we forced the expression of a TCRbeta chain isolated from a peptide-independent allore
59 The nature and CDR3 loop composition of the TCRbeta chain played a dominant role in determining pMHC
61 bled during thymocyte development influences TCRbeta chain selection and peripheral Vbeta repertoire.
62 an independent validation, we analysed 5,711 TCRbeta chain sequences from reactive CD4 T cells from 2
64 iple sclerosis, we used high-throughput deep TCRbeta chain sequencing to assess millions of individua
65 understanding of complementary TCRalpha and TCRbeta chain utilization is very limited for pathogen-
66 h peptide were established by the transgenic TCRbeta chain, and that this was compensated by addition
68 or knowledge of variable region usage in the TCRbeta chain, resulting in a comprehensive, unbiased TC
73 xpressed transgene P14 T-cell receptor beta (TCRbeta) chain and CD8beta or did not (WT and KO mice, r
79 encing approach, we determined TCRalpha- and TCRbeta-chain usage, as well as alphabetaTCR pairs expre
80 a tandem, multistep process to quantify rare TCRbeta-chain variable sequences of ASTs in large polycl
81 most cells that fail to produce a functional TCRbeta-chain will die instead of adopting the alternati
82 oded pairwise interactions.Rather, identical TCRbeta chains can have altered peptide-MHC (pMHC) bindi
87 riant TCRalpha chain and a restricted set of TCRbeta chains recognize structurally diverse antigens i
90 pervariable CDR3 regions on the TCRalpha and TCRbeta chains, and obtaining the paired sequences of th
94 ls sorted to remove cells bearing endogenous TCRbeta-chains can express newly generated TCRbeta molec
96 with the prerearranged Vbeta in cell surface TCRbeta-chains were observed in Vbeta14(NT) and Vbeta8(T
97 lf of these lymphocytes expressed Vbeta14(+) TCRbeta-chains, even though similar steady-state levels
98 plenic alphabeta T cells expressed Vbeta8(+) TCRbeta-chains, only half of these lymphocytes expressed
99 cells expressed only Vbeta14(+) or Vbeta8(+) TCRbeta-chains, respectively, and lacked Vbeta rearrange
100 ctory aGVHD patients showed a more conserved TCRbeta clonal structure between different biopsy sites
102 g revealed oligoclonal expansion of specific TCRbeta clonotypes in CD8(+)PD-1(+) compared with CD8(+)
105 ic traits of CD8(+) TILs and TCR beta chain (TCRbeta) clonotypic frequency in melanoma tumors to iden
106 We determined the genomic sequence of 244 TCRbeta coding junctions from 112 (63 male, 49 female) s
113 inated by crossing B6x56R with CD4(-/)(-) or TCRbeta(-/-)delta(-/-) mice, and the effects on anti-dsD
114 mmadelta T cell homeostatic proliferation in TCRbeta(-/-)/delta(-/-) mice was not altered in the pres
115 sustained advantage following transfer into TCRbeta(-/-)/delta(-/-) mice, NK1.1(+) gammadelta T cell
116 ing of both immune receptor chains (VH+VL or TCRbeta/delta+TCRalpha/gamma) at the single-cell level f
117 is here using a series of public and private TCRbeta derived from autoimmune encephalomyelitis-associ
118 at patients with OS had marked reductions in TCRbeta diversity compared with control subjects, as exp
119 During this investigation, we focused on TCRbeta(+) DN thymocytes and found that there are at lea
120 least three functionally distinct subsets of TCRbeta(+) DN thymocytes: TCRbeta(+) DN3E, TCRbeta(+) DN
121 nterleukin 7 (IL-7) promotes the survival of TCRbeta(-) DN thymocytes by inducing expression of the p
125 istinct subsets of TCRbeta(+) DN thymocytes: TCRbeta(+) DN3E, TCRbeta(+) DN3L, and TCRbeta(+) DN4.
130 cl-2 expression was not dependent on Gads in TCRbeta(+) DN4 cells, but proliferation of TCRbeta(+) DN
132 -) mice were crossed with Bcl-xL-, Bcl2-, or TCRbeta-expressing transgenic mice, a modest level of co
133 e current study confirms that CD3epsilon and TCRbeta expression are present on the FC at the time of
135 a recombination efficiency governs monogenic TCRbeta expression, thereby restraining the expression o
138 rs, the cumulative frequency of these public TCRbeta family members was a highly discriminatory indic
141 o results predicted by the accepted model of TCRbeta feedback inhibition, we found that expression of
142 haracterized by a systemic deficit in CD4(+) TCRbeta(+) Foxp3(+) CD25(+) T regulatory cells, increase
145 pression of either a preassembled functional TCRbeta gene (Vbeta1(NT)) or the prosurvival BCL2 protei
146 Rbeta rearrangements needed for a productive TCRbeta gene further increased frequencies of ATM-defici
147 among T cell progenitors that have completed TCRbeta gene rearrangement without producing a functiona
150 d gender-specific V(D)J recombinase-mediated TCRbeta gene usage and coding joint processing at immune
152 ression of a fully rearranged and functional TCRbeta gene, and most cells that fail to produce a func
153 is study, we demonstrate that a preassembled TCRbeta gene, but not a preassembled DbetaJbeta complex
154 typical B-cell marker, T-cell receptor beta (TCRbeta) gene rearrangement indicated a T-cell origin.
157 s method involves sequencing of TCRalpha and TCRbeta genes, and amplifying functional genes character
158 go RAG-dependent rearrangement of endogenous TCRbeta genes, driving surface expression of novel TCRs.
159 xpression of both prerearranged TCRalpha and TCRbeta genes, indicating a critical role for TCR signal
162 ling and T-cell antigen receptor beta-chain (TCRbeta) genotyping on sequential genital skin biopsies,
163 ere, we introduce a strictly monovalent anti-TCRbeta H57 Fab' ligand that, when coupled to a supporte
164 vo administration of mAbs specific for mouse TCRbeta (H57-597), TCRalpha or CD3 promptly reduced the
166 iCD8alpha IEL but not TCRgammadelta(+) IEL, TCRbeta(+) IEL, or intestinal epithelial cells, can prom
167 d developmentally specific V(D)J recombinase TCRbeta immune gene rearrangements and coding joint proc
168 that signaling pathways required to initiate TCRbeta-induced survival and proliferation are distinct
171 the large IgH, Igkappa, TCRalpha/delta, and TCRbeta loci fold into compact structures that place the
174 We have previously shown that of the two TCRbeta locus (Tcrb) D segments, Dbeta1 is flanked by an
175 -J recombination is outlined using the mouse TCRbeta locus as a model with frequent comparisons to th
176 ocyte development, molecular analyses of the TCRbeta locus in gammadelta cells and the TCRgamma and d
177 s) at which DNA cleavage is defective or how TCRbeta locus sequences contribute to these defects.
178 ps of DNA cleavage by the RAG proteins using TCRbeta locus V, D, and J RSS oligonucleotide substrates
179 sed to drive rearrangement of the endogenous TCRbeta locus, effecting cell rescue through the express
181 sors, accompanied by reduced numbers of both TCRbeta(low) immature single-positive CD8(+) cells and d
182 , resulting in the appearance of CD4(+)CD8(-)TCRbeta(-/low) thymocytes indistinguishable from DP thym
191 that three of the identified CMV-associated TCRbeta molecules bind CMV in vitro, and, moreover, we u
196 cers were identified as predominantly DX5(+) TCRbeta(+) NKT cells, and a comparable response could be
197 tion of the NMD factor UPF3b does not impair TCRbeta NMD, thereby distinguishing it from classical NM
201 ease the frequencies of cells with biallelic TCRbeta or IgH expression while decreasing the frequency
205 oglobulin heavy, T-cell receptor (TCR)alpha, TCRbeta, or TCRgamma chains expressed in a population of
206 public, but not private, disease-associated TCRbeta paired with endogenously rearranged TCRalpha end
207 t a hydrophobic patch created after TCRalpha-TCRbeta pairing has a role in maintaining the conformati
208 etains information about individual TCRalpha-TCRbeta pairs, TCRs of interest can be expressed and use
210 K/Akt pathway, which is required for pTalpha/TCRbeta (pre-TCR)-induced survival, differentiation, and
211 ich cells expressing functionally rearranged TCRbeta proliferate and differentiate into CD4(+)CD8(+)
215 two of six public, but none of five private TCRbeta provoked spontaneous early-onset autoimmunity in
216 ision, RAG reexpression mediates extrathymic TCRbeta rearrangement and results in a population of pos
217 the Pten gene prior to the formation of the TCRbeta rearrangement, produced early in development.
218 apoptosis were able to undergo a successful TCRbeta rearrangement, they exhibited a highly abnormal
219 ith clonal TCRalpha but no comparable clonal TCRbeta rearrangement, yielding events that would not no
222 subject to feedback inhibition, we analyzed TCRbeta rearrangements in Vbeta14(Rep) mice containing a
223 DJbeta complex that decreases the number of TCRbeta rearrangements needed for a productive TCRbeta g
224 idiopathic CP and a positive correlation of TCRbeta rearrangements with disease severity scores.
227 ly devised assay, we characterized 48 unique TCRbeta recombination signal sequence (RSS) end insertio
230 equencing revealed a significant increase in TCRbeta repertoire diversity and reduced clonality in bo
232 y, we systematically analyzed changes of the TCRbeta repertoire driven by EAE and pregnancy using TCR
236 antify where limitations imposed on the Treg TCRbeta repertoire results in a population of Tregs that
240 ection of CD8alphaalpha precursors and their TCRbeta repertoire, but not in the maintenance of CD8alp
245 scovered a substantial number of public CDR3-TCRbeta segments that were identical in mice and humans.
246 ell development at the T cell receptor beta (TCRbeta) selection checkpoint and during positive select
247 lyzed sharing and similarity of CMV-specific TCRbeta sequences and identified 63 public or related se
248 on events in different cells, while abundant TCRbeta sequences are primarily derived from large clone
252 sequencing was used to identify >18 x 10(6) TCRbeta sequences from the CNSs, periphery, and thymi of
253 can be used to capture and pair TCRalpha and TCRbeta sequences from total T-cell RNA, enabling revers
254 In this study, we assessed TCRalpha and TCRbeta sequences of mouse tTreg and thymic conventional
255 Mapping experiments revealed the identity of TCRbeta sequences that elicit a switch to UPF3b dependen
257 implicate positive selection for promiscuous TCRbeta sequences that likely evade negative selection,
258 sequencing data, we found that abundant CDR3-TCRbeta sequences were clustered within networks generat
259 ments of the naive CD8(+) T-cell repertoire, TCRbeta sequences with convergent features were (i) pres
260 ose CMV status from the resulting catalog of TCRbeta sequences with high specificity and sensitivity
263 ng a combination approach of high-throughput TCRbeta sequencing and multiparametric flow cytometry, w
265 s using fluorescence-activated cell sorting, TCRbeta sequencing, and RNA-Seq, in reactive and hyporea
267 is study, we performed T cell receptor beta (TCRbeta) sequencing of virus-specific CD8 T cells during
268 When this gene is in-frame, Trbv5 evades TCRbeta-signaled feedback inhibition and recombines by i
269 d on these findings, we propose CMV-specific TCRbeta signatures as a biomarker for an antiviral T cel
272 results in the appearance of CD4(+)Vbeta5(-)TCRbeta(+) T cells, coinciding with Rag1, Rag2, and TdT
274 t are completely devoid of T cells (B6.129P2-Tcrbeta(tm1Mom) Tcrdelta(tm1Mom)/J) show protection agai
275 lar TCR-beta protein and decreased levels of tcrbeta transcript are expressed by T cells cultured in
276 sites up-regulated an alternatively spliced TCRbeta transcript that skipped the mutations independen
279 smic fraction mRNA ratio that results in few TCRbeta transcripts escaping to the cytoplasmic fraction
280 d that NIPS is not exclusively a property of TCRbeta transcripts, and we identified non-TCRbeta seque
282 repertoire breadth to a non-self-antigen, a TCRbeta transgenic mouse model (EF4.1) expressing a limi
283 pertoire of T(reg) cells in Foxp3-sufficient TCRbeta-transgenic mice, suggesting that these self-reac
284 cluding radial chromosome translocations and TCRbeta translocations, compared with cells lacking Atm
285 urther insight into this question, we used a TCRbeta transmembrane domain mutant model that is defect
286 Here we show that cholesterol bound to the TCRbeta transmembrane region keeps the TCR in a resting,
287 l receptor (TCR) chains, TCRalpha (TRAC) and TCRbeta (TRBC), were deleted in T cells to reduce TCR mi
288 ffector memory-RA(+) subsets with restricted TCRbeta usage and nearly monoclonal CDR3 containing nove
289 that FOXP3(+) Tregs possess highly exclusive TCRbeta usage from conventional T cells, in blood, and a
290 We studied the T-cell receptor beta-chain (TCRbeta) usage and phenotypes of peanut-activated, CD154
291 tepwise assembly and subsequent selection of TCRbeta V region exons during thymocyte development.
292 ombined the DNA of one T cell receptor beta (TCRbeta) V-to-DJ-joined allele in a functional configura
293 d/or TCRgamma rearrangements but no complete TCRbeta variable diversity joining rearrangement in surf
294 ghly biased, with a predominant usage of the TCRbeta variable gene 2 (TRBV2) in vaccinees as well as
299 drive oncogene expression differ markedly in TCRbeta (which are exclusively enhancer driven) and TCRa